Literature DB >> 27943361

Persistent hepatitis C virus-associated cryoglobulinemic vasculitis following virus eradication after direct-acting antiviral therapy.

Marina Artemova1, Dzhamal Abdurakhmanov2, Tatiana Ignatova2, Nikolay Mukhin1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27943361     DOI： 10.1002/hep.28981

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  7 in total

1.  KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2018-09-19

2.  Direct-Acting Antivirals and Mixed Cryoglobulinemia Vasculitis: Long-Term Outcome of Patients Achieving HCV Eradication.

Authors:  Salvatore Sollima; Laura Milazzo; Spinello Antinori; Massimo Galli
Journal:  Am J Gastroenterol       Date:  2017-11       Impact factor: 10.864

Review 3.  Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection.

Authors:  Iman Ibrahim Salama; Hala M Raslan; Ghada A Abdel-Latif; Somaia I Salama; Samia M Sami; Fatma A Shaaban; Aida M Abdelmohsen; Walaa A Fouad
Journal:  World J Hepatol       Date:  2022-06-27

4.  Survival and Prognostic Factors in Mixed Cryoglobulinemia: Data from 246 Cases.

Authors:  Cesare Mazzaro; Luigino Dal Maso; Endri Mauro; Valter Gattei; Michela Ghersetti; Pietro Bulian; Giulia Moratelli; Gabriele Grassi; Francesca Zorat; Gabriele Pozzato
Journal:  Diseases       Date:  2018-05-03

5.  A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort.

Authors:  Loreta A Kondili; Monica Monti; Maria Giovanna Quaranta; Laura Gragnani; Valentina Panetta; Giuseppina Brancaccio; Cesare Mazzaro; Marcello Persico; Mario Masarone; Ivan Gentile; Pietro Andreone; Salvatore Madonia; Elisa Biliotti; Roberto Filomia; Massimo Puoti; Anna Ludovica Fracanzani; Diletta Laccabue; Donatella Ieluzzi; Carmine Coppola; Maria Grazia Rumi; Antonio Benedetti; Gabriella Verucchi; Barbara Coco; Liliana Chemello; Andrea Iannone; Alessia Ciancio; Francesco Paolo Russo; Francesco Barbaro; Filomena Morisco; Luchino Chessa; Marco Massari; Pierluigi Blanc; Anna Linda Zignego
Journal:  Hepatology       Date:  2022-01-19       Impact factor: 17.298

6.  The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia.

Authors:  Koji Muro; Naohiro Toda; Shinya Yamamoto; Motoko Yanagita
Journal:  Intern Med       Date:  2020-09-30       Impact factor: 1.271

7.  Hematological and Genetic Markers in the Rational Approach to Patients With HCV Sustained Virological Response With or Without Persisting Cryoglobulinemic Vasculitis.

Authors:  Laura Gragnani; Serena Lorini; Silvia Marri; Umberto Basile; Veronica Santarlasci; Monica Monti; Francesco Madia; Luisa Petraccia; Cristina Stasi; Niccolò Marello; Cecilia Napodano; Francesco Annunziato; Anna Linda Zignego
Journal:  Hepatology       Date:  2021-05-26       Impact factor: 17.425
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.